ORX:STO
Orexo AB
5,35 SEK
arrow_downward
-1,29%(-0,070) 1D
21-окт., 17:29:38 GMT+2 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORX...
Open
5,52 SEK
High
5,65 SEK
Low
5,35 SEK
Mkt. cap
187,93 млн
Avg. vol.
115,34 миң
Volume
57,41 миң
P/E ratio
0,23
52-wk high
40,10 SEK
52-wk low
5,35 SEK
EPS
23,61 SEK
Shares outstanding
35,13 млн
No. of employees
61
Open
5,52 SEK
High
5,65 SEK
Low
5,35 SEK
Mkt. cap
187,93 млн
Avg. vol.
115,34 миң
Volume
57,41 миң
P/E ratio
0,23
52-wk high
40,10 SEK
52-wk low
5,35 SEK
EPS
23,61 SEK
Shares outstanding
35,13 млн
No. of employees
61
News stories
From web sources and news partners
FinancialContent
·
26 мүнөт мурун
CVB Financial’s (NASDAQ:CVBF) Q3 2026 sales beat estimates
Kitco
·
18 мүнөт мурун
Gold gains as Treasury yields stabilize, Nasdaq surges despite Fed tightening concerns - Kitco PM Report
IndexBox
·
45 мүнөт мурун
Bitcoin Outperforms Nasdaq: Relative Strength Analysis, Price Levels and Momentum - News and Statistics
AOL.com
·
1 саат мурун
Prediction: 2026 Will Be the S&P 500's 4th Straight Double-Digit Year
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB